CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated (CORT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 88% planned / 12% discretionary
Largest single sale: $3.3M.
Where they traded
Last open-market purchase: March 17, 2026 , by BAKER G LEONARD JR .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Swisher Daniel N JR | Director | Sell 10b5-1 | 1,500 | $74.07 | $111.1K | None left | |
| Maduck Sean 2 fills | Other | Sell 10b5-1 | 13,159 | $82.25 | $1.1M | 14,480 −47.6% of holding | |
| Maduck Sean | Other | Sell 10b5-1 | 11,841 | $81.42 | $964.1K | 9,938 −54.4% of holding | |
| Vieira Roberto Wandenkolk 2 fills | President, Oncology | Sell 10b5-1 | 8,333 | $80.89 | $674.1K | 5,622 −59.7% of holding | |
| WILSON JAMES N 3 fills | Director | Sell 10b5-1 | 10,000 | $114.81 | $1.1M | 1,057,889 −0.9% of holding | |
| Maduck Sean 2 fills | See Remarks | Sell 10b5-1 | 24,587 | $116.28 | $2.9M | 18,682 −56.8% of holding | |
| Lyon Joseph Douglas 2 fills | See Remarks | Sell 10b5-1 | 9,190 | $116.13 | $1.1M | 10,427 −46.8% of holding | |
| Vieira Roberto Wandenkolk 3 fills | President, Oncology | Sell 10b5-1 | 8,333 | $116.10 | $967.4K | 11,179 −42.7% of holding | |
| Lyon Joseph Douglas | See Remarks | Sell 10b5-1 | 810 | $115.40 | $93.5K | 5,683 −12.5% of holding | |
| Maduck Sean | See Remarks | Sell 10b5-1 | 413 | $115.54 | $47.7K | 9,938 −4% of holding | |
| Vieira Roberto Wandenkolk | President, Oncology | Sell 10b5-1 | 296 | $100.82 | $29.8K | 3,946 −7% of holding | |
| WILSON JAMES N 3 fills | Director | Sell 10b5-1 | 10,000 | $110.69 | $1.1M | 1,067,743 −0.9% of holding | |
| Lyon Joseph Douglas 2 fills | See Remarks | Sell 10b5-1 | 10,000 | $113.49 | $1.1M | 7,871 −56% of holding | |
| Vieira Roberto Wandenkolk 7 fills | President, Oncology | Sell 10b5-1 | 58,333 | $110.76 | $6.5M | 38,975 −59.9% of holding | |
| Maduck Sean 3 fills | See Remarks | Sell 10b5-1 | 25,000 | $114.43 | $2.9M | 23,025 −52.1% of holding | |
| Park Kimberly | Director | Sell | 26,685 | $122.55 | $3.3M | None left | |
| Maduck Sean 2 fills | See Remarks | Sell 10b5-1 | 30,955 | $125.58 | $3.9M | 15,625 −66.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.